To authorize the Secretary of Health and Human Services to award grants to States and political subdivisions of States to support the improvement, renovation, or modernization of infrastructure at clinical laboratories that will help to improve SARS-CoV-2 and COVID-19 testing and response activities, including the expansion and enhancement of testing capacity at such laboratories.

Bill 117 HR 1818, also known as the Clinical Laboratory Infrastructure Improvement Act, aims to provide funding for the improvement, renovation, or modernization of infrastructure at clinical laboratories in order to enhance SARS-CoV-2 and COVID-19 testing and response activities. The bill authorizes the Secretary of Health and Human Services to award grants to States and political subdivisions of States to support these efforts.

The main goal of the bill is to expand and enhance testing capacity at clinical laboratories, which plays a crucial role in the ongoing fight against the COVID-19 pandemic. By investing in the infrastructure of these laboratories, the bill seeks to improve the efficiency and effectiveness of testing and response activities, ultimately helping to curb the spread of the virus.

Overall, the Clinical Laboratory Infrastructure Improvement Act is a proactive measure to address the challenges posed by the COVID-19 pandemic and strengthen the nation's ability to respond to future public health crises. It emphasizes the importance of investing in healthcare infrastructure to ensure the safety and well-being of all Americans.